MARKET

MBII

MBII

Marrone Bio Innovations Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.060
-0.020
-1.85%
After Hours: 1.100 +0.04 +3.77% 16:13 05/18 EDT
OPEN
1.070
PREV CLOSE
1.080
HIGH
1.100
LOW
1.050
VOLUME
389.90K
TURNOVER
107.34K
52 WEEK HIGH
1.948
52 WEEK LOW
0.5492
MARKET CAP
193.28M
P/E (TTM)
-9.0753
1D
5D
1M
3M
1Y
5Y
Marrone Bio's (MBII) Earnings and Revenues Miss Estimates in Q1
Marrone Bio (MBII) witnessed increased sales of row crop products in the first quarter, offset by lower sales into specialty crop markets.
Zacks · 1d ago
Cannabis Stock Gainers And Losers From May 16, 2022
GAINERS: Sundial Growers (NASDAQ:SNDL) shares closed up 21.09% at $0.47
Benzinga · 2d ago
Marrone Bio Innovations, Inc. (MBII) Reports Q1 Loss, Lags Revenue Estimates
Marrone Bio Innovations, Inc. (MBII) delivered earnings and revenue surprises of -300% and 8.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/11 21:15
Marrone Bio Innovations: Q1 Earnings Insights
Marrone Bio Innovations (NASDAQ:MBII) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:30 PM. Here's what investors need to know about the announcement.
Benzinga · 05/11 20:43
Marrone Bio GAAP EPS of -$0.04 misses by $0.02, revenue of $11.1M misses by $1.67M
Marrone Bio press release (NASDAQ:MBII): Q1 GAAP EPS of -$0.04 misses by $0.02. Revenue of $11.1M (+0.5% Y/Y) misses by $1.67M.
Seekingalpha · 05/11 20:28
Marrone Bio Innovations Q1 EPS $(0.04) Misses $(0.02) Estimate, Sales $11.10M Miss $12.60M Estimate
Marrone Bio Innovations (NASDAQ:MBII) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.02) by 100 percent. This is a 100 percent decrease over losses of $(0.02) per share
Benzinga · 05/11 20:02
-- Earnings Flash (MBII) MARRONE BIO INNOVATIONS Posts Q1 Revenue $11.1M, vs. Street Est of $12.8M
MT Newswires · 05/11 16:19
Marrone Bio Q1 2022 Earnings Preview
Marrone Bio (NASDAQ:MBII) is scheduled to announce Q1 earnings results on Wednesday, May 11th, after market close. The consensus EPS Estimate is -$0.01 and the consensus Revenue Estimate is $12.77M
Seekingalpha · 05/10 21:35
More
No Data
Learn about the latest financial forecast of MBII. Analyze the recent business situations of Marrone Bio Innovations Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
50.00%Buy
50.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average MBII stock price target is 1.375 with a high estimate of 2.000 and a low estimate of 0.9000.
High2.000
Average1.375
Low0.9000
Current 1.060
EPS
Actual
Estimate
-0.03-0.02-0.02-0.01
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 94
Institutional Holdings: 80.70M
% Owned: 44.27%
Shares Outstanding: 182.34M
TypeInstitutionsShares
Increased
22
6.67M
New
13
2.33M
Decreased
18
1.05M
Sold Out
12
18.29M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Agricultural Chemicals
-4.45%
Chemicals
-2.99%
Key Executives
Non-Executive Chairman/Independent Director
Robert Woods
Chief Executive Officer/Director
Kevin Helash
Chief Financial Officer
Ladon Johnson
Executive Vice President/Chief Compliance Officer/General Counsel/Secretary
Linda Moore
Senior Vice President/Chief Technology Officer
Amit Vasavada
Senior Vice President
Keith Pitts
Senior Vice President
Matti Tiainen
Vice President
Timothy Johnson
Director
Pamela Marrone
Independent Director
Lara Lee
Independent Director
Yogesh Mago
Independent Director
Keith McGovern
Independent Director
Zachary Wochok
Independent Director
Stuart Woolf
No Data
No Data
About MBII
Marrone Bio Innovations, Inc. is an agricultural company that supports farming practices through the discovery, development and sale of biological products for crop protection, crop health and crop nutrition. The Company’s products include Emergen, Foramin, Foramin ST, Grandevo, Haven, Jet-Ag, Jet-Oxide, Majestene, Pacesetter, Regalia, Stargus, UBP, UBP ST, Venerate and Zelto. Its product categories include products, which are referred to as biopesticides, bioinsecticides, bionematicides, biofungicides, biostimulants and bionutrition. Its pipeline consists of products in three categories: bioprotection, seed and soil health, and plant health. The Company’s markets include row crops, such as corn and soybeans; fruits and vegetables, such as tomatoes, leafy greens and cucurbits, trees; nuts and vines, such as almonds and grapes, and greenhouse production, such as ornamentals and medicinal plants.

Webull offers kinds of Marrone Bio Innovations Inc stock information, including NASDAQ:MBII real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBII stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MBII stock methods without spending real money on the virtual paper trading platform.